TABLE 2.
Actual injection site locations measured for the 30 m post-injection MRI.
| Cohort | Injection sites measured in MR image 0.5 h post-injection (mm) | ||
| X (L-R) | Y (front-back) | Z (deep) | |
| Group A (+APPSwInd, +Amyloid-β/plaques) | 2.73 ± 0.37 | −4.81 ± 0.21 | 2.42 ± 0.42 |
| Group B (−APPSwInd, +Amyloid-β/plaques) | 3.03 ± 0.17 | −4.62 ± 0.19 | 2.80 ± 0.26 |
| Group C (+APPSwInd, −Amyloid-β/plaques) | 2.96 ± 0.25 | −4.55 ± 0.23 | 2.62 ± 0.54 |
| WT Group (−APPSwInd, −Amyloid-β/plaques) | 2.90 ± 0.32 | −4.63 ± 0.30 | 2.43 ± 0.45 |
| Farthest Distance from Centroid (mm) | 0.81 | 0.65 | 0.97 |